Background: Acinetobacter baumannii (A. baumannii) has emerged as a nosocomial
pathogen especially in the intensive care units (ICUS). It's enlisted at the top of urgent threat …

Objective Nosocomial infection caused by carbapenem-resistant Acinetobacter baumannii is
a worldwide problem and treatment options remain controversial. This study investigated the …

Background Extensive drug resistance of Acinetobacter baumannii is a serious problem in
the clinical setting. It is therefore important to find active antibiotic combinations that could be …

Acinetobacter baumannii has been an important consideration in the development of
effective combination therapy. Hence, the in vitro activities of colistin sulfate and sulbactam …

Objectives To determine the in vitro activities and interactions of imipenem, colistin and
tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter …

Background: Acinetobacter species, specially, Acinetobacter baumannii, is known, as an
important opportunistic pathogen, with a variety of infections such as pneumonia …

Acinetobacter baumannii has emerged worldwide as an important nosocomial and
opportunistic pathogen, particularly in intensive care units (7). Treatment is difficult due to …

Objective: Acinetobacter baumannii (A. baumannii) can develop resistance to various
antimicrobial agents via different mechanisms. Hence, the aim of this study was to …

Background: Carbapenem-resistant Acinetobacter baumannii has emerged as one of the
most troublesome pathogens in the healthcare setting both globally and locally. Objectives …

Background: The Acinetobacter species, particularly A. baumannii, has emerged as one of
the main causes of nosocomial infections in recent years. The high prevalence of drug …